Skip to main content
. 2016 Oct 14;3:44. doi: 10.3389/fmed.2016.00044

Figure 4.

Figure 4

Treatment efficacy (time to cure) and tolerability (adverse event incidence) of racecadotril in comparison with Saccharomyces boulardii [“Saccharomyces.”; (55)]. Data are means of 197 vs. 207 patients. *P < 0.05 vs. Saccharomyces with no error bar reported by original authors, and no statistical analysis reported for tolerability.